Positive results for Lipid inCode® in NHS clinical study _ Lipid inCode® offers greater diagnostic information for hypercholesterolemia sufferers over current NHS standard
Oxford, UK. GENinCode Plc (AIM: GENI), the predictive genetics company focused on the prevention of cardiovascular disease, announces the successful completion of its NHS clinical study and [...]